Non-insulino-dependant Diabetes in Infants and Teenagers
NCT ID: NCT04174508
Last Updated: 2021-11-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2020-03-24
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In Reunion island, about 30 children a year seem to reveal diabetes before the age of 18 years but no precise data has ever been published on this subject.
Indeed, while type 1 diabetes (insulin-dependent autoimmune) represents historically the majority of cases of diabetes revealed at pediatric age (about 90%), since a little more than 10 years other types of diabetes seem emerge at pediatric age. This is particularly the case of type 2 diabetes in connection with the global epidemic of obesity.
The purpose of the investigator's study is the exhaustive prospective collection of all cases of diabetes revealed before the age of 18 in the Reunion region over a period of 5 years.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with a diagnosis that revealed diabetes according to criteria defined by WHO (World Health Organization) before 18 years of age
* Parents who signed the participation consent
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de la Réunion
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laure HOUDON, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire de La REUNION
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Groupe Hospitalier Est Réunion
Saint-Benoît, , France
Centre Hospitalier Universitaire Réunion
Saint-Denis, , France
Centre Hospitalier Ouest Réunion
Saint-Paul, , France
Centre Hospitalier Universitaire Réunion
Saint-Pierre, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Lucie AUZANNEAU
Role: primary
Lucie AUZANNEAU
Role: primary
Lucie AUZANNEAU
Role: primary
Lucie
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014/CHU/10
Identifier Type: -
Identifier Source: org_study_id